These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 33410801)

  • 1. Clinical and Demographic Characteristics of HIV Post-Exposure Prophylaxis Users in New York City.
    Adan MA; Zucker J; Carnevale C; Grant WL; Cohall AT; Gordon P; Olender SA; Sobieszczyk ME
    J Health Care Poor Underserved; 2020; 31(2):672-681. PubMed ID: 33410801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
    Walters SM; Rivera AV; Starbuck L; Reilly KH; Boldon N; Anderson BJ; Braunstein S
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S383-S391. PubMed ID: 28604443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    Misra K; Udeagu CC
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):132-140. PubMed ID: 28902677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study.
    Peng Q; Liu X; Tang X; Zhang Q; Zhao J; Zheng C; Zhao F; Zhou Y; Zhang L; Sun L; Zhang H; Jia X; Song Y; Cao T; Wang S; Rao M; Chen Z; Wang H; He Y
    Chin Med J (Engl); 2022 Nov; 135(22):2730-2737. PubMed ID: 36719360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes.
    Johnson KA; Chen MJ; Kohn R; Sachdev D; Bacon O; Lee S; Cohen SE
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):818-825. PubMed ID: 33512849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consultations for HIV post-exposure prophylaxis before and after health insurance coverage of pre-exposure prophylaxis to a university-based emergency department in Germany.
    Böhm L; Jensen BO; Schelzig H; Luedde T; Bernhard M
    HIV Res Clin Pract; 2023 Dec; 24(1):2207977. PubMed ID: 37151090
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomedical HIV Prevention among Gay Male Couples: A Qualitative Study of Motivations and Concerns.
    Bosco SC; Pawson M; Parsons JT; Starks TJ
    J Homosex; 2021 Jul; 68(8):1353-1370. PubMed ID: 31809246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure prophylaxis: an underutilized biomedical HIV prevention method among gay, bisexual and other men who have sex with men in China.
    Hou J; Wu Y; Xie L; Meng S; Fu R; Zheng H; He N; Huang X; Xu J; Meyers K
    AIDS Care; 2020 Dec; 32(12):1573-1580. PubMed ID: 32188267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Ard KL; Edelstein ZR; Bolduc P; Daskalakis D; Gandhi AD; Krakower DS; Myers JE; Keuroghlian AS
    Clin Infect Dis; 2019 Feb; 68(5):860-864. PubMed ID: 30020422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV Pre-exposure Prophylaxis (PrEP) Cascade at NYC Sexual Health Clinics: Navigation Is the Key to Uptake.
    Pathela P; Jamison K; Blank S; Daskalakis D; Hedberg T; Borges C
    J Acquir Immune Defic Syndr; 2020 Apr; 83(4):357-364. PubMed ID: 31904700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City.
    Mehta SA; Silvera R; Bernstein K; Holzman RS; Aberg JA; Daskalakis DC
    Sex Transm Infect; 2011 Jun; 87(4):344-8. PubMed ID: 21357600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure Prophylaxis Awareness, Knowledge, Access and Use Among Three Populations in New York City, 2016-17.
    Koblin BA; Usher D; Nandi V; Tieu HV; Bravo E; Lucy D; Miles L; Ortiz G; Kindlon MJ; Parisi DM; Frye V
    AIDS Behav; 2018 Aug; 22(8):2718-2732. PubMed ID: 29858737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate PrEP when accessing PEP: A service evaluation.
    Cockbain B; Whitlock G;
    HIV Med; 2022 Nov; 23(10):1108-1112. PubMed ID: 35352455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and Use of PEP and PrEP Among Key Populations Tested in Community Centers in Portugal.
    Simões D; Meireles P; Rocha M; Freitas R; Aguiar A; Barros H
    Front Public Health; 2021; 9():673959. PubMed ID: 34368050
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence and Characteristics of HIV Post-Exposure Prophylaxis for a Population in Tel Aviv of Men who have Sex with Men.
    Oz N; Alon D; Stein GY; Turner D
    Isr Med Assoc J; 2017 Apr; 19(4):257-261. PubMed ID: 28480682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.